Hoang, T. D., Olsen, C. H., Mai, V. Q., Clyde, P. W., & Shakir, M. K. (2013). Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. The Journal of Clinical Endocrinology and Metabolism, 98(5), 1982-1990. https://doi.org/10.1210/jc.2012-4107
Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. doi:10.1210/jc.2012-4107
Hoang, Thanh D., et al. "Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study." The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 5, 2013, pp. 1982-1990.
For EndNote, Zotero or Mendeley:
License
No open license is recorded for this paper. Reuse terms are set by the publisher.
Author affiliations
2 institutions
Walter Reed National Military Medical Center025cem651
Uniformed Services University of the Health Sciences04r3kq386
Linked to ROR, the Research Organization Registry
Abstract
Context
Patients previously treated with desiccated thyroid extract (DTE), when being switched to levothyroxine (L-T₄), occasionally did not feel as well despite adequate dosing based on serum TSH levels.
Objective
Our objective was to investigate the effectiveness of DTE compared with L-T₄ in hypothyroid patients.
Design and Setting
We conducted a randomized, double-blind, crossover study at a tertiary care center.
Patients
Patients (n = 70, age 18-65 years) diagnosed with primary hypothyroidism on a stable dose of L-T₄ for 6 months were included in the study.
Intervention
Patients were randomized to either DTE or L-T₄ for 16 weeks and then crossed over for the same duration.
Outcome Measures
Biochemical and neurocognitive tests at baseline and at the end of each treatment period were evaluated.
Results
There were no differences in symptoms and neurocognitive measurements between the 2 therapies. Patients lost 3 lb on DTE treatment (172.9 ± 36.4 lb vs 175.7 ± 37.7 lb, P < .001). At the end of the study, 34 patients (48.6%) preferred DTE, 13 (18.6%) preferred L-T₄, and 23 (32.9%) had no preference. In the subgroup analyses, those patients who preferred DTE lost 4 lb during the DTE treatment, and their subjective symptoms were significantly better while taking DTE as measured by the general health questionnaire-12 and thyroid symptom questionnaire (P < .001 for both). Five variables were predictors of preference for DTE.
Conclusion
DTE therapy did not result in a significant improvement in quality of life; however, DTE caused modest weight loss and nearly half (48.6%) of the study patients expressed preference for DTE over L-T₄. DTE therapy may be relevant for some hypothyroid patients.
